Here we demonstrated that galanin is increased in NAFLD patients and is correlated to proinflammatory factors in NASH, including MCP-1 and leptin, suggesting a protective responder to NASH inflammation, even though early studies also suggested a deleterious effect of galanin in obesity and hepatic steatosis. The gene discussed is GAL; the disease is metabolic dysfunction-associated steatotic liver disease.